SaNOtize’s NONS Phase 2 study proves efficacy in COVID-19 treatment

By Nikita Chaurasia  Date: 2021-03-16

SaNOtize’s NONS Phase 2 study proves efficacy in COVID-19 treatment

Vancouver-headquartered biotechnology organization, SaNOtize Research & Development Corp has announced the results of its Phase 2 trials of Nitric Oxide Nasal Spray, abbreviated as NONS, for the treatment of patients diagnosed with COVID-19.

For those uninitiated, NONS treatment is based on NO (nitric oxide), a natural nano molecule produced in the human body which exhibits anti-microbial properties and characteristics proven to have a direct effect on the Coronavirus. Moreover, the treatment is designed to kill the virus in the upper airways, barricading its incubation and entry into the lungs.

According to reliable sources, the phase 2 clinical trials indicated that SaNOtize’s NONS is an effective and safe antiviral treatment that prevents the transmission of the coronavirus, shortens its course, and significantly reduces the severity of symptoms in individuals already diagnosed.

SaNOtize has issued a press release stating that the Phase 2 clinical trials found that early treatment of COVID-19 patients with NONS substantially reduced the levels of SARS-CoV-2 coronavirus, including in individuals experiencing high viral loads. Notably, NONS is the only treatment that has proven to reduce viral loads in humans.

If sources are to be believed, the preliminary data comes from a double-blind, placebo-controlled, randomized clinical trial round conducted on 79 confirmed cases of COVID-19. Furthermore, the trials recorded an average viral log of 1.362 in the first 24 hours, which is a decline of around 95%.

This was followed by a 99% drop of the viral load within 72 hours of the commencement of the test, sources confirmed.

Gilly Regev, Co-founder, and CEO of SaNOtize, was reported saying that the biotech company will now focus on efficiently administering the vaccine among the masses and will work towards bringing an end to the ongoing pandemic as well as preventing future outbreaks of relevant viruses.

SaNOtize is currently seeking Emergency Use Authorization from regulatory authorities in Canada and the United Kingdom.

Source credits –

 https://www.businesswire.com/news/home/20210315005197/en/UK-Clinical-Trial-Confirms-SaNOtize%E2%80%99s-Breakthrough-Treatment-for-COVID-19

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

BMW Group to opt for green steel in vehicle production from 2025

BMW Group to opt for green steel in vehicle production from 2025

By Nikita Chaurasia

As climatic changes and other environmental issues take center stage, the BMW Group, to minimize carbon dioxide (CO2) emissions at the core of its supply chain, has reportedly agreed to use green steel from Swedish firm H2 Green Steel beginning in 20...

Apple unveils 16-inch MacBook Pro with high-performance M1 processors

Apple unveils 16-inch MacBook Pro with high-performance M1 processors

By Nikita Chaurasia

Tech giant Apple, Inc. has recently unveiled the 16-inch MacBook Pro, which promises extraordinary design and performance. The model can be customized with the all-new M1 Pro and M1 Max processors.    These new 10-core processors are ...

Kedrion Biopharma expands to North America with Prometic acquisition

Kedrion Biopharma expands to North America with Prometic acquisition

By Nikita Chaurasia

Prometic Life Sciences has developed the first FDA-approved treatment for Congenital Plasminogen Deficiency. This acquisition will enable easy access to advanced therapies for patients suffering from this rare disease. Kedrion Biopharma Inc. has...

Facebook Pages to reduce focus on Likes and followers for Indian users

Facebook Pages to reduce focus on Likes and followers for Indian users

By Nikita Chaurasia

Facebook Inc. has reportedly removed Likes from Facebook Pages for its Indian users to make the platform more user-friendly and easier to understand. This redesign of Facebook Pages was launched in January 2021 and has been rolled out for Indian user...

Merchant commerce platform Pine Labs eyeing USD 1 Bn Nasdaq listing

Merchant commerce platform Pine Labs eyeing USD 1 Bn Nasdaq listing

By Nikita Chaurasia

India is likely to witness a record number of IPOs this year, with several companies eyeing public listing to raise funds if the market sentiment remains positive. One such company, Pine Labs is reportedly planning to list itself on Nasdaq by October...